Skip to main content

1 Result(s)

within S. Pace Remove this filter Medicine & Public Health Remove this filter

and

  1. No Access

    Article

    Phase-I dose finding and pharmacokinetic study of the novel hydrophilic camptothecin ST-1968 (namitecan) in patients with solid tumors

    Purpose: This is a first-in-human, phase I, dose-escalation study to determine the maximum tolerated dose (MTD) of intravenous, flat-dosed ST-1968 (namitecan), a new hydrophilic camptothecan deri...

    M. Joerger, D. Hess, A. Delmonte, E. Gallerani, P. Barbieri… in Investigational New Drugs (2015)